Temporal ultrasound for monitoring tocilizumab treatment in giant cell arteritis: seeing beyond serum markers?

Ann Rheum Dis. 2021 Nov;80(11):e184. doi: 10.1136/annrheumdis-2019-216527. Epub 2019 Nov 5.

Authors

Gerasimos Evangelatos¹, George E Fragoulis², Alexios Iliopoulos³

Affiliations

¹ Rheumatology Department, 417 Army Share Fund Hospital (NIMTS), Athens, Greece gerevag@gmail.com.
² Rheumatology Unit, First Department of Propaedeutic Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
³ Rheumatology Department, 417 Army Share Fund Hospital (NIMTS), Athens, Greece.

PMID: 31690621
DOI: 10.1136/annrheumdis-2019-216527

No abstract available

Keywords: DMARDs (biologic); giant cell arteritis; ultrasonography.

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Biomarkers
Giant Cell Arteritis* / diagnostic imaging
Giant Cell Arteritis* / drug therapy
Humans
Temporal Arteries / diagnostic imaging

Substances

Antibodies, Monoclonal, Humanized
Biomarkers
tocilizumab